|
NOTA-NOC
|
|
|
|
Hynic-[Tyr3]Octreotide,
|
HYNIC-TOC trifluoroacetate
|
257943-19-4
|
|
PSMA-ligand- 1
|
PSMA-ligand-1
|
1610413-97-2
|
|
PSMA- 11
|
4,6,12,19-Tetraazadocosane-1,3,7-tricarboxylic acid, 22-[3-[[[2-[[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl](carboxymethyl)amino]ethyl](carboxymethyl)amino]methyl]-4-hydroxyphenyl]-5,13,20-trioxo-, (3S,7S)-
|
1366302-52-4
|
|
NOTA-Octreotide
|
NOTA-奥曲肽
|
|
|
PSMA- 1007
|
PSMA1007
|
|
|
NOTA-TATE
|
NOTA-TATE
|
|
|
NA
|
Maximin H39 多肽
|
|
|
PSMA-617
|
1702967-37-0
|
1702967-37-0
|
|
FAPI04;FAPI-4;FAPI 4;FAPI
|
FAPI-4
|
2374782-02-0
|
|
Ac-Lys(Ac)-D-Ala-D-Ala-OH
|
人工三肽底物
|
28845-97-8
|
|
Protein Kinase C (beta) Peptide
|
蛋白激酶C(Β)肽
|
309247-50-5
|
|
G-V-L-S-N-V-I-G-Y-L-K-K-L-G-T-G-A-L-N-A-V-L-K-Q
|
GLY-VAL-LEU-SER-ASN-VAL-ILE-GLY-TYR-LEU-LYS-LYS-LEU-GLY-THR-GLY-ALA-LEU-ASN-ALA-VAL-LEU-LYS-GLN: GVLSNVIGYLKKLGTGALNAVLKQ
|
136831-50-0
|
|
Trofinetide
|
曲非奈肽
|
853400-76-7
|
|
(S)-5-tert-butoxy-4-(3-((S)- 1,5-di-tert-butoxy- 1,5- dioxopentan-2-yl)ureido)-5-oxopentanoic acid
|
(S)-5-叔丁氧基-4-(3-((S)-1,5-二-叔丁氧基-1,5-二氧代-2-戊基)脲啶)-5-氧代戊酸
|
1026987-94-9
|
|
NTFAPI, (S)-2,2'-(7-(2-(4-(3-((4-((2-(2-cyano-4,4- difluoropyrrolidin- 1-yl)-2-oxoethyl)carbamoyl)quinolin-6- yl)oxy)propyl)piperazin- 1-yl)-2-oxoethyl)- 1,4,7-triazonane- 1,4- diyl)diacetic acid
|
NTFAPI
|
2374782-03-1
|
|
DOTA-TATE, DOTA-[Tyr3]-Octreotate
|
N-[[4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基]乙酰基]-D-苯丙氨酰基-L-半胱氨酰基-L-酪氨酰基-D-色氨酰基-L-赖氨酰基-L-苏氨酰基-L-半胱氨酰基-L-苏氨酸, 环(2→7)-二硫化物
|
177943-88-3
|
|
4,5-dihydro-5,5-dimethyl-3-isoxazolyl Carbamimidothioic acid ester hydrochloride (1:1)
|
4,5-二氢-5,5-二甲基-3-异硫脲-异噁唑盐酸盐
|
869002-97-1
|
|
SH-FAPI-4, (S)-N-(2-(2-cyano-4,4-difluoropyrrolidin- 1-yl)- 2-oxoethyl)-6-(3-(4-(3-mercaptopropanoyl)piperazin- 1- yl)propoxy)quinoline-4-carboxamide
|
|
|
|
Lecirelin(Dalmarelin)Acetate
|
醋酸兰瑞肽
|
61012-19-9
|
|
(S)-Di-Tert-Butyl 2-(3-((S)-6-Amino- 1-(Tert-Butoxy)- 1- Oxohexan-2-Yl)Ureido)Pentanedioate
|
(S)-DI-TERT-BUTYL 2-(3-((S)-6-AMINO-1-(TERT-BUTOXY)-1-OXOHEXAN-2-YL)UREIDO)PENTANEDIOATE
|
1025796-31-9
|
|
Pefachrome tPA
|
|
161572-29-8
|
|
Boc-Phe-Gly-Gly-OH
|
Boc-FGG三肽
|
103340-16-5
|
|
Gly-Val-Ser-Trp-Gly-Leu-Arg
|
|
1801959-12-5
|
|
N-Glycyl-L-tyrosine
|
甘氨酰-L-酪氨酸
|
658-79-7
|
|
2-METHYL-4-(TRIFLUOROMETHYL)-1,3-THIAZOLE-5-CARBOXYLIC ACID
|
2-甲基-4-三氟甲基噻唑-5-羧酸
|
117724-63-7
|
|
NH2-UAMC1110
|
NH2-UAMC1110，成纤维细胞活化蛋白（fap）抑制剂，UAMC1110的衍生物
|
|
|
Benzyl carbamate
|
氨基甲酸苄酯
|
621-84-1
|
|
Lipopeptide Acetate
|
六胜肽
|
|
|
B7-33
|
B7-33
|
|
|
Pentixafor
|
Pentixafor
|
1341207-62-2
|
|
dihydrosomatostatin
|
二氢生长抑素
|
40958-31-4
|
|
Dolastatin 10
|
海兔毒素10
|
110417-88-4
|
|
H-Phe-Pro-βNA
|
H-PHE-PRO-BETANA
|
76122-99-1
|
|
Palmitoyl Tetrapeptide-10
|
棕榈酰四肽-10
|
887140-79-6
|
|
PSMA-617 linker, Vipivotide tetraxetan Linker, (10S, 14S)- 1- (4-(aminomethyl)cyclohexyl)-3-(naphthalen-2-ylmethyl)- 1,4, 12-trioxo- 2,5, 11, 13-tetraazahexadecane- 10, 14, 16-tricarboxylic acid
|
Vipivotide tetraxetan Linker
|
1703768-74-4
|
|
4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro- 1-pyrrolidinyl]-2-oxoethyl]-6-[3-(1-piperazinyl)propoxy]-
|
FAPI
|
2471983-20-5
|
|
DOTA-Octreotide
|
DOTA-OCTREOTIDE
|
|
|
HYINC-FAPI-4
|
HYINC-FAPI-4
|
|
|
HBED-CC-tris
|
|
|
|
Cholecystokinin Octapeptide free acid (desulfated)
|
胆囊收缩素free acid (desulfated)
|
103974-46-5
|
|
H-ILE-VAL-OH
|
异亮氨酰-缬氨酸
|
41017-96-3
|
|
BZ-ILE-GLU-GLY-ARG-PNA
|
BZ-ILE-GLU-GLY-ARG-PNA
|
59068-47-2
|
|
360 MMP FRET Substrate III
|
荧光底物肽MMP-2
|
135662-07-6
|
|
UAMC1110, (S)-N-(2-(2-cyano-4,4-difluoropyrrolidin- 1-yl)- 2-oxoethyl)quinoline-4-carboxamide
|
(S)-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺
|
1448440-52-5
|
|
(DES-HIS)-ACTH (1-24)
|
(DES-HIS)-ACTH (1-24)
|
1926163-11-2
|
|
FAPI- 14 ,(S)-6-[3-(4-Boc- 1-piperazinyl)propoxy]-N-[2-(2- cyano-4,4-difluoro- 1-pyrrolidinyl)-2-oxoethyl]quinoline-4-carboxamide
|
(S)-6-[3-(4-Boc-1-哌嗪基)丙氧基]-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺
|
2374782-82-6
|
|
H-VAL-PRO-OH·HCL
|
L-缬氨酰-L-脯氨酸盐酸盐
|
105931-64-4
|
|
F-PSMA 1007
|
|
2093321-18-5
|